| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $839.2M | +7.0% |
| Cost of Revenue | $151.6M | +12.0% |
| Gross Profit | $687.6M | +5.9% |
| R&D Expense | $132.3M | -6.7% |
| SG&A Expense | $114.0M | +9.4% |
| Operating Income | $75.4M | +574.4% |
| Interest Expense | $415K | -12.1% |
| Pre-tax Income | $83.6M | +644.3% |
| Income Tax | -$85.3M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $312.8M | +8.7% |
| Accounts Receivable | $222.7M | +5.8% |
| Current Assets | $595.1M | +8.0% |
| Total Assets | $943.9M | +20.6% |
| Current Liabilities | $484.9M | +18.3% |
| Stockholders' Equity | $278.1M | +49.4% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $203.8M | +19.7% |
| Capital Expenditures | $4.1M | +26.1% |
| Investing Cash Flow | -$5.5M | -4.4% |
| Financing Cash Flow | -$170.6M | -25.8% |
| Free Cash Flow | $199.7M | +19.6% |
| -517.9% |
| Net Income | $168.9M | +572.1% |
| EPS (Basic) | $3.85 | +581.3% |
| EPS (Diluted) | $3.75 | +568.7% |